Cancer trials suspended for new patients
Beth Israel Deaconess Medical Center temporarily closed all its cancer trials to new patients last week, after audits found that several researchers had not properly submitted patient data to the committee that oversees oncology research and to trial sponsors.
“Some of our clinical trials were not running with the high standards that we expect,’’ Randy Mason, vice president of research operations, wrote in an e-mail to hospital executives and physician leaders last week.
He described the lapses as involving documentation and reporting compliance and said the hospital has not found any “issues of patient harm.’’
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- Carondelet to Pay $35M to Settle Fraud Allegations
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- 3 Traits Personality Assessments Can't Reveal
- CA Powers Up $80M HIE to 'Create Value in the Data'